217 related articles for article (PubMed ID: 9371593)
1. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
Demeret C; Desaintes C; Yaniv M; Thierry F
J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
3. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
Demeret C; Yaniv M; Thierry F
J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
[TBL] [Abstract][Full Text] [Related]
4. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein.
Steger G; Corbach S
J Virol; 1997 Jan; 71(1):50-8. PubMed ID: 8985322
[TBL] [Abstract][Full Text] [Related]
7. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
8. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
10. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition.
Nishimura A; Ono T; Ishimoto A; Dowhanick JJ; Frizzell MA; Howley PM; Sakai H
J Virol; 2000 Apr; 74(8):3752-60. PubMed ID: 10729150
[TBL] [Abstract][Full Text] [Related]
12. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
13. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
14. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
15. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.
May M; Dong XP; Beyer-Finkler E; Stubenrauch F; Fuchs PG; Pfister H
EMBO J; 1994 Mar; 13(6):1460-6. PubMed ID: 8137827
[TBL] [Abstract][Full Text] [Related]
16. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
Stubenrauch F; Straub E; Fertey J; Iftner T
Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
[TBL] [Abstract][Full Text] [Related]
17. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
Francis DA; Schmid SI; Howley PM
J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
[TBL] [Abstract][Full Text] [Related]
18. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression.
Yan J; Li Q; Lievens S; Tavernier J; You J
J Virol; 2010 Jan; 84(1):76-87. PubMed ID: 19846528
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
Fertey J; Hurst J; Straub E; Schenker A; Iftner T; Stubenrauch F
J Virol; 2011 Mar; 85(6):2918-26. PubMed ID: 21191025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
